Disability outcomes and dose escalation with etanercept, adalimumab, and infliximab in rheumatoid arthritis patients: a US-based retrospective comparative effectiveness study by Schabert, V.F., Bruce, B., Ferrufino, C.F., Globe, D.R., Harrison, D.J., Lingala, B., Fries, J.F.

Get full text